Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD2981 |
Phase 2 |
0.8926 |
High Similarity |
NPD2983 |
Phase 2 |
0.8926 |
High Similarity |
NPD2982 |
Phase 2 |
0.88 |
High Similarity |
NPD3027 |
Phase 3 |
0.8793 |
High Similarity |
NPD5283 |
Phase 1 |
0.879 |
High Similarity |
NPD3018 |
Phase 2 |
0.8571 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8492 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.845 |
Intermediate Similarity |
NPD1613 |
Approved |
0.845 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8197 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.816 |
Intermediate Similarity |
NPD3705 |
Approved |
0.814 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8134 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.813 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8102 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.8074 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.8016 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD228 |
Approved |
0.7914 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7879 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7787 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7787 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7752 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7752 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD7157 |
Approved |
0.774 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7721 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7635 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7612 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7612 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7541 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7536 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7482 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD17 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7422 |
Intermediate Similarity |
NPD7534 |
Approved |
0.7422 |
Intermediate Similarity |
NPD7533 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7402 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7398 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7398 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7379 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7377 |
Intermediate Similarity |
NPD290 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7364 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7364 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7361 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7348 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7338 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD3537 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7324 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7315 |
Intermediate Similarity |
NPD37 |
Approved |
0.7313 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7313 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2107 |
Clinical (unspecified phase) |
0.7295 |
Intermediate Similarity |
NPD968 |
Approved |
0.729 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7287 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7286 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7266 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7255 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD291 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7237 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7231 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD821 |
Approved |
0.7218 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7197 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7194 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7192 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD919 |
Approved |
0.719 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7165 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7154 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1351 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1350 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1349 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7113 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7107 |
Intermediate Similarity |
NPD940 |
Approved |
0.7107 |
Intermediate Similarity |
NPD846 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6031 |
Approved |
0.709 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD4359 |
Approved |
0.709 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7071
|
Intermediate Similarity |
NPD6355 |
Discontinued |